# Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars

> **NCT05484401** · PHASE3 · COMPLETED · sponsor: **Reckitt Benckiser Healthcare (UK) Limited** · enrollment: 294 (actual)

## Conditions studied

- Tooth, Impacted
- Tooth Diseases
- Stomatognathic Diseases

## Interventions

- **DRUG:** Ibuprofen 200Mg Oral Cap
- **DRUG:** Ibuprofen 200Mg Oral Tablet
- **OTHER:** Placebo Liquid Capsule
- **OTHER:** Placebo Tablets

## Key facts

- **NCT ID:** NCT05484401
- **Lead sponsor:** Reckitt Benckiser Healthcare (UK) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-09
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-06-15
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05484401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05484401, "Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05484401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*